[Translation] A Phase I Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Oral APG-5918 in Patients with Advanced Solid Tumors or Hematologic Malignancies
评估晚期实体瘤患者或血液系统恶性肿瘤患者口服APG-5918的安全性、耐受性、有效性和药代动力学特征。
[Translation] To evaluate the safety, tolerability, efficacy and pharmacokinetics of oral APG-5918 in patients with advanced solid tumors or hematologic malignancies.